Continuous treatment with FTS confers resistance to apoptosis and affects autophagy.
High percentage of human cancers involves alteration or mutation in Ras proteins, including the most aggressive malignancies, such as lung, colon and pancreatic cancers. FTS (Salirasib) is a farnesylcysteine mimetic, which acts as a functional Ras inhibitor, and was shown to exert anti-tumorigenic effects in vitro and in vivo. Previously, we have demonstrated that short-term treatment with FTS also induces protective autophagy in several cancer cell lines. Drug resistance is frequently observed in cancer cells exposed to prolonged treatment, and is considered a major cause for therapy inefficiency. Therefore, in the present study, we examined the effect of a prolonged treatment with FTS on drug resistance of HCT-116 human colon cancer cells, and the involvement of autophagy in this process. We found that cells grown in the presence of FTS for 6 months have become resistant to FTS-induced cell growth inhibition and cell death. Furthermore, we discovered that the resistant cells exhibit altered autophagy, reduced apoptosis and changes in Ras-related signaling pathways following treatment with FTS. Moreover we found that while FTS induces an apoptosis-related cleavage of p62, the FTS-resistant cells were more resistant to apoptosis and p62 cleavage.
Department of Neurobiology. Tel-Aviv University, Ramat-Aviv, Israel.
Eran
E
Schmukler
Department of Neurobiology. Tel-Aviv University, Ramat-Aviv, Israel.
Eya
E
Wolfson
Department of Biological Chemistry; The Weizmann Institute of Science; Rehovot, Israel.
Zvulun
Z
Elazar
Department of Neurobiology. Tel-Aviv University, Ramat-Aviv, Israel.
Yoel
Y
Kloog
Department of Neurobiology. Tel-Aviv University, Ramat-Aviv, Israel.
Ronit
R
Pinkas-Kramarski
D017209:Apoptosis / Q000187:drug effects*; D001343:Autophagy / Q000187:drug effects*; D016923:Cell Death / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D019008:Drug Resistance, Neoplasm; D005204:Farnesol / Q000031:analogs & derivatives* / Q000494:pharmacology; D011905:Genes, ras / Q000187:drug effects; D045325:HCT116 Cells / Q000187:drug effects; D006801:Humans; D060888:Real-Time Polymerase Chain Reaction; D012459:Salicylates / Q000494:pharmacology*; D015398:Signal Transduction / Q000187:drug effects
D012459:Salicylates; C093323:farnesylthiosalicylic acid; D005204:Farnesol